A study published in the January 19 issue of the Archives of Otolaryngology - Head and Neck Surgery shows that there was a nationwide increase in the prevalence of pediatric methicillin-resistant Staphylococcus aureus head and neck infections from January 2001 to December 2006.
The increase in antibiotic-resistant infections has become a big concern for researchers and clinicians over the years. MRSA was once a condition that was only found in hospital settings. However, over the last decade the number of outbreaks has grown among patients without risk factors.
In an attempt to identify trends in the susceptibility of antibiotic-resistant infections, researchers from the USA's Emory University School of Medicine and Children's Healthcare of Atlanta studied data on pediatric patients from nationwide hospitals. They reviewed a total of 21,009 pediatric head and neck S. aureus infections from 300 hospitals nationwide that occurred between January 1, 2001 and December 31, 2006.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze